Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bill Cheliak Insider Profile
4 Followers
Bill Cheliak, Director at Tetra Bio-Pharma, holds 90.00K shares in Solarvest BioEnergy (Ticker: TSE:SVS.H), holds 1.57M shares in Tetra Bio-Pharma (Ticker: TSE:TBP). Most recently, Bill Cheliak Bought ― shares of Solarvest BioEnergy on Apr 19, 2023 for an estimated value of 2.10K.
Profitable Transactions
1 out of 7 Profitable Transactions
Average Return
-28.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bill Cheliak holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bill Cheliak
Bill Cheliak's Trading History
Tetra Bio-Pharma
May 23, 2020
Director
Informative Buy
4.80K
C$31.39K
Solarvest BioEnergy
Apr 19, 2023
Director
Informative Buy
2.10K
C$2.25K
List of latest transactions for each holding click on a transaction to see Bill Cheliak's performance on stock
You May Also Like
Bill Cheliak insider profile FAQ
What is the percentage of profitable transactions made by Bill Cheliak?
The percentage of profitable transactions made by Bill Cheliak is 14%.
What is the average return per transaction made by Bill Cheliak?
The average return per transaction made by Bill Cheliak is -28.50%.
What stocks does Bill Cheliak hold?
Bill Cheliak holds: TSE:TBP, TSE:SVS.H stocks.
What was Bill Cheliak’s latest transaction?
Bill Cheliak latest transaction was an Informative Buy of C$2.10K.
What was Bill Cheliak's most profitable transaction?
Bill Cheliak’s most profitable transaction was an Informative Buy of TSE:TBP stock on May 23, 2020. The return on the trade was 57.40%.
What is Bill Cheliak's role in Tetra Bio-Pharma?
Bill Cheliak's role in Tetra Bio-Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.